Electric-Field Pixel Array Biosensor for Catalytic Ion Detection in Diabetic Nephropathy
ACS Biomaterials Science & Engineering · 10.08.2026 · 12 (8) · 4510-4521
DOI: 10.1021/acsbiomaterials.6c00565 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 25.07.2026. Verfasst von Mei-Ching Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Nephrology, Lin-Kou Chang Gung Memorial Hospital, Taoyuan333423, Taiwan. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Biosensing Techniques, Methylamines. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Ministry of Science and Technology (MOST), Taiwan.
Abstract (Originalsprache)
Trimethylamine N-oxide (TMAO) has recently emerged as a clinically relevant biomarker for the early diagnosis and risk stratification of chronic diabetic nephropathy and cardiovascular disease. Here, we report an electric-field-driven pixel array urine biosensor for the assessment of diabetic nephropathy and for elucidating the relationship among urine TMAO, glucose, and urine microalbumin-to-creatinine ratio (UACR). The purified trimethylamine N-oxide reductase (torA) enzyme catalyzes the reduction of TMAO to trimethylamine (TMA) and H2O, during which generated H+ ions modulate the local ionic environment and attenuate the device electric field. The proposed pixel array biosensor, integrated with a dedicated readout circuit, enables quantitative TMAO detection over a broad UACR range, exhibiting a sensitivity of 8.2 mV/(mg/g) over a dynamic range up to 1200 mg/g. In contrast, glucose shows an initial increase at low UACR but becomes highly variable above 30 mg/g, indicating poor correlation with progressive albuminuria due to preserved tubular reabsorption at early stages of glomerular injury. The device further achieves a sensitivity of 2.5 mV/μM, a response time of 10 s, a reproducibility of 98%, and a low long-term offset drift of 0.3 mV. Only 5 μL of urine is required for simultaneous quantification of TMAO and glucose. Overall, the proposed system provides a rapid, sensitive, and user-friendly point-of-care platform for early risk assessment of chronic kidney disease in diabetic populations, enabling improved accessibility for home-based monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Nephrology, Lin-Kou Chang Gung Memorial Hospital, Taoyuan333423, Taiwan.
- College of Medicine, Chang Gung University, Taoyuan333323, Taiwan.
- Department of Electrical Engineering, Chang Gung University, Taoyuan33302, Taiwan.
- Department of Trauma and Emergency, Chang Gung Memorial Hospital, Taoyuan33302, Taiwan.
ORCID-Profile: Tzu-Wei Chung, Wei-Cheng Lin
Förderung
- Ministry of Science and Technology (MOST), Taiwan
Zitieren
APA
Yu, M. C., Chung, T. W., Lin, W. C., & Liao, C. H. (2026). Electric-Field Pixel Array Biosensor for Catalytic Ion Detection in Diabetic Nephropathy. ACS Biomaterials Science & Engineering, 12(8), 4510-4521. https://doi.org/10.1021/acsbiomaterials.6c00565
Vancouver
Yu MC, Chung TW, Lin WC, Liao CH. Electric-Field Pixel Array Biosensor for Catalytic Ion Detection in Diabetic Nephropathy. ACS Biomaterials Science & Engineering. 2026;12(8):4510-4521. doi:10.1021/acsbiomaterials.6c00565
BibTeX
@article{Yu2026,
author = {Yu, Mei-Ching and Chung, Tzu-Wei and Lin, Wei-Cheng and Liao, Chien-Hung},
title = {Electric-Field Pixel Array Biosensor for Catalytic Ion Detection in Diabetic Nephropathy},
journal = {ACS Biomaterials Science & Engineering},
year = {2026},
volume = {12},
number = {8},
pages = {4510--4521},
doi = {10.1021/acsbiomaterials.6c00565}
}
EUVIMED